» Articles » PMID: 14749383

Ogt-dependent X-chromosome-linked Protein Glycosylation is a Requisite Modification in Somatic Cell Function and Embryo Viability

Overview
Journal Mol Cell Biol
Specialty Cell Biology
Date 2004 Jan 30
PMID 14749383
Citations 229
Authors
Affiliations
Soon will be listed here.
Abstract

The Ogt gene encodes a glycosyltransferase that links N-acetylglucosamine to serine and threonine residues (O-GlcNAc) on nuclear and cytosolic proteins. Efforts to study a mammalian model of Ogt deficiency have been hindered by the requirement for this X-linked gene in embryonic stem cell viability, necessitating the use of conditional mutagenesis in vivo. We have extended these observations by segregating Ogt mutation to distinct somatic cell types, including neurons, thymocytes, and fibroblasts, the latter by an approach developed for inducible Ogt mutagenesis. We show that Ogt mutation results in the loss of O-GlcNAc and causes T-cell apoptosis, neuronal tau hyperphosphorylation, and fibroblast growth arrest with altered expression of c-Fos, c-Jun, c-Myc, Sp1, and p27. We further segregated the mutant Ogt allele to parental gametes by oocyte- and spermatid-specific Cre-loxP mutagenesis. By this we established an in vivo genetic approach that supports the ontogeny of female heterozygotes bearing mutant X-linked genes required during embryogenesis. Successful production and characterization of such female heterozygotes further indicates that mammalian cells commonly require a functional Ogt allele. We find that O-GlcNAc modulates protein phosphorylation and expression among essential and conserved cell signaling pathways.

Citing Articles

Brain O-GlcNAcylation: Bridging physiological functions, disease mechanisms, and therapeutic applications.

Chen L, Jiang H, Licinio J, Wu H Mol Psychiatry. 2025; .

PMID: 40033044 DOI: 10.1038/s41380-025-02943-z.


Genetic gradual reduction of OGT activity unveils the essential role of O-GlcNAc in the mouse embryo.

Formichetti S, Sadowska A, Ascolani M, Hansen J, Ganter K, Lancrin C PLoS Genet. 2025; 21(1):e1011507.

PMID: 39787076 PMC: 11717234. DOI: 10.1371/journal.pgen.1011507.


Diverse perspectives on proteomic posttranslational modifications to address EGFR-TKI resistance in non-small cell lung cancer.

Ma Y, Zhang F, Li J, Li J, Li Y Front Cell Dev Biol. 2025; 12():1436033.

PMID: 39777265 PMC: 11703921. DOI: 10.3389/fcell.2024.1436033.


The post-translational modification O-GlcNAc is a sensor and regulator of metabolism.

Morales M, Pratt M Open Biol. 2024; 14(10):240209.

PMID: 39474868 PMC: 11523104. DOI: 10.1098/rsob.240209.


O-GlcNAc impacts mitophagy via the PINK1-dependent pathway.

Alghusen I, Carman M, Wilkins H, Strope T, Gimore C, Fedosyuk H Front Aging Neurosci. 2024; 16:1387931.

PMID: 39175808 PMC: 11339348. DOI: 10.3389/fnagi.2024.1387931.


References
1.
Marek K, Vijay I, Marth J . A recessive deletion in the GlcNAc-1-phosphotransferase gene results in peri-implantation embryonic lethality. Glycobiology. 1999; 9(11):1263-71. DOI: 10.1093/glycob/9.11.1263. View

2.
Kearse K, Hart G . Lymphocyte activation induces rapid changes in nuclear and cytoplasmic glycoproteins. Proc Natl Acad Sci U S A. 1991; 88(5):1701-5. PMC: 51092. DOI: 10.1073/pnas.88.5.1701. View

3.
Priatel J, Chui D, Hiraoka N, Simmons C, Richardson K, Page D . The ST3Gal-I sialyltransferase controls CD8+ T lymphocyte homeostasis by modulating O-glycan biosynthesis. Immunity. 2001; 12(3):273-83. DOI: 10.1016/s1074-7613(00)80180-6. View

4.
Lubas W, Hanover J . Functional expression of O-linked GlcNAc transferase. Domain structure and substrate specificity. J Biol Chem. 2001; 275(15):10983-8. DOI: 10.1074/jbc.275.15.10983. View

5.
Berton F, Cornet V, Iborra C, Garrido J, Dargent B, Fukuda M . Synaptotagmin I and IV define distinct populations of neuronal transport vesicles. Eur J Neurosci. 2000; 12(4):1294-302. DOI: 10.1046/j.1460-9568.2000.00013.x. View